CGTX (STOCKS)
Cognition Therapeutics, Inc. Common Stock
$0.950000
+0.045400 (+5.02%)
Prev close: $0.904600
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Lisa R. Ricciardi
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $87.72M
- Employees
- 25
- P/E (TTM)
- -2.84
- P/B (TTM)
- 2.53
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
7
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$-0.05 | $-0.09 | +0.0370 | +43.53% |
|
Sep 2025 (Q3)
|
$-0.06 | $-0.10 | +0.0420 | +41.18% |
|
Jun 2025 (Q2)
|
$-0.11 | $-0.11 | -0.0012 | -1.10% |
|
Mar 2025 (Q1)
|
$-0.14 | $-0.11 | -0.0275 | -24.44% |
Financial Statements
| Revenues | $0.00 |
| Operating Expenses | $47.80M |
| Research and Development | $37.19M |
| Other Operating Expenses | $10.61M |
| Operating Income/Loss | -$47.80M |
| Income/Loss From Continuing Operations After Tax | -$23.49M |
| Income/Loss From Continuing Operations Before Tax | -$23.49M |
| Income Tax Expense/Benefit | $0.00 |
| Net Income/Loss | -$23.49M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$23.49M |
| Net Income/Loss Available To Common Stockholders, Basic | -$23.49M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.32 |
| Diluted Earnings Per Share | -$0.32 |
| Basic Average Shares | 72,766,983 |
| Diluted Average Shares | 72,766,983 |
| Assets | $48.39M |
| Current Assets | $47.99M |
| Prepaid Expenses | $1.07M |
| Other Current Assets | $46.92M |
| Noncurrent Assets | $399.00K |
| Fixed Assets | $93.00K |
| Other Non-current Assets | $306.00K |
| Liabilities | $14.12M |
| Current Liabilities | $13.92M |
| Accounts Payable | $1.12M |
| Wages | $1.57M |
| Other Current Liabilities | $11.24M |
| Noncurrent Liabilities | $195.00K |
| Equity | $34.27M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $34.27M |
| Liabilities And Equity | $48.39M |
| Net Cash Flow From Operating Activities | -$24.59M |
| Net Cash Flow From Operating Activities, Continuing | -$24.59M |
| Net Cash Flow From Investing Activities | $9.00K |
| Net Cash Flow From Investing Activities, Continuing | $9.00K |
| Net Cash Flow From Financing Activities | $36.57M |
| Net Cash Flow From Financing Activities, Continuing | $36.57M |
| Net Cash Flow | $11.99M |
| Net Cash Flow, Continuing | $11.99M |
| Comprehensive Income/Loss | -$23.49M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$23.49M |
| Other Comprehensive Income/Loss | -$23.49M |